• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Management of immunological adverse events in patients treated with immune checkpoint inhibitors: ASCO clinical practice guideline summary].

作者信息

Krause Mechthild

机构信息

Klinik für Strahlentherapie, Universitätsklinikum Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Deutschland.

出版信息

Strahlenther Onkol. 2019 Apr;195(4):365-366. doi: 10.1007/s00066-019-01436-7.

DOI:10.1007/s00066-019-01436-7
PMID:30770936
Abstract
摘要

相似文献

1
[Management of immunological adverse events in patients treated with immune checkpoint inhibitors: ASCO clinical practice guideline summary].[接受免疫检查点抑制剂治疗患者免疫不良反应的管理：美国临床肿瘤学会临床实践指南摘要]
Strahlenther Onkol. 2019 Apr;195(4):365-366. doi: 10.1007/s00066-019-01436-7.
2
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.接受免疫检查点抑制剂治疗患者免疫相关不良事件的管理：美国临床肿瘤学会临床实践指南摘要
J Oncol Pract. 2018 Apr;14(4):247-249. doi: 10.1200/JOP.18.00005. Epub 2018 Mar 8.
3
New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity.NCCN 指南更新：免疫治疗相关毒性的识别与管理。
J Natl Compr Canc Netw. 2018 May;16(5S):594-596. doi: 10.6004/jnccn.2018.0047.
4
Clinical Development and Initial Approval of Novel Immune Checkpoint Inhibitors in Oncology: Insights From a Global Regulatory Perspective.从全球监管视角看新型肿瘤免疫检查点抑制剂的临床研发和首次批准
Clin Pharmacol Ther. 2019 Mar;105(3):582-597. doi: 10.1002/cpt.1123. Epub 2018 Sep 12.
5
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature.免疫检查点抑制剂诱发的肌肉骨骼和风湿性疾病：文献综述
Curr Drug Saf. 2018;13(3):150-164. doi: 10.2174/1574886313666180508122332.
6
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors.癌症患者接受免疫检查点抑制剂治疗的免疫相关不良反应。
Curr Rheumatol Rep. 2018 Sep 6;20(10):65. doi: 10.1007/s11926-018-0770-0.
7
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.局部晚期非小细胞肺癌的根治性和辅助放疗：美国临床肿瘤学会临床实践指南对美国放射肿瘤学会循证临床实践指南的认可。
J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.
8
Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management.免疫检查点抑制剂相关的神经不良事件：诊断与管理。
Curr Neurol Neurosci Rep. 2018 Feb 1;18(1):3. doi: 10.1007/s11910-018-0810-1.
9
Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology.免疫检查点抑制剂的心脏毒性：心脏肿瘤学与免疫学的交汇
Circulation. 2017 Nov 21;136(21):1989-1992. doi: 10.1161/CIRCULATIONAHA.117.029626.
10
Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology.肿瘤免疫检查点抑制剂研发的经验教训
Integr Cancer Ther. 2018 Dec;17(4):1012-1015. doi: 10.1177/1534735418801524. Epub 2018 Sep 19.

引用本文的文献

1
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors.基于问卷的 PD-1/PD-L1 免疫检查点抑制剂治疗癌症患者免疫相关不良事件的检测。
BMC Cancer. 2021 Mar 24;21(1):314. doi: 10.1186/s12885-021-08006-0.
2
Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John's wort skin oil.在全脑放疗、靶向治疗以及包括贯叶金丝桃油在内的其他药物摄入期间出现严重皮肤毒性。
Strahlenther Onkol. 2021 Jul;197(7):644-649. doi: 10.1007/s00066-020-01739-0. Epub 2021 Jan 24.

本文引用的文献

1
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.免疫检查点抑制剂治疗患者免疫相关不良反应的管理：美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.